Focus Partners Wealth Acquires 29,409 Shares of Danaher Co. (NYSE:DHR)

Focus Partners Wealth raised its holdings in Danaher Co. (NYSE:DHR) by 19.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 177,596 shares of the conglomerate’s stock after acquiring an additional 29,409 shares during the period. Focus Partners Wealth’s holdings in Danaher were worth $40,818,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Full Sail Capital LLC increased its position in Danaher by 2.5% during the 4th quarter. Full Sail Capital LLC now owns 2,730 shares of the conglomerate’s stock worth $627,000 after purchasing an additional 66 shares in the last quarter. Elefante Mark B bought a new position in shares of Danaher in the 4th quarter valued at $3,428,000. Ensign Peak Advisors Inc lifted its stake in shares of Danaher by 1.9% in the 4th quarter. Ensign Peak Advisors Inc now owns 1,306,654 shares of the conglomerate’s stock valued at $299,942,000 after acquiring an additional 24,888 shares during the last quarter. Ethic Inc. boosted its holdings in shares of Danaher by 44.7% during the 4th quarter. Ethic Inc. now owns 56,333 shares of the conglomerate’s stock valued at $12,931,000 after acquiring an additional 17,402 shares in the last quarter. Finally, Ewing Morris & Co. Investment Partners Ltd. bought a new stake in Danaher during the 4th quarter worth $621,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently commented on DHR shares. JPMorgan Chase & Co. cut their price target on Danaher from $280.00 to $260.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 22nd. Royal Bank of Canada reiterated an “outperform” rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Barclays upped their price target on shares of Danaher from $205.00 to $215.00 and gave the company an “overweight” rating in a research report on Tuesday, April 22nd. Citigroup reiterated a “buy” rating on shares of Danaher in a report on Monday, April 7th. Finally, Jefferies Financial Group decreased their price objective on Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a report on Tuesday, April 22nd. Five investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $264.40.

Danaher Price Performance

Shares of NYSE DHR opened at $189.42 on Friday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm’s 50-day moving average price is $198.39 and its 200-day moving average price is $219.21. The firm has a market capitalization of $135.56 billion, a P/E ratio of 35.88, a P/E/G ratio of 2.66 and a beta of 0.80. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The firm had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.58 billion. Equities research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.68%. Danaher’s dividend payout ratio is currently 24.85%.

Insider Transactions at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 11.10% of the stock is currently owned by insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.